mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
necrostatin-7 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.03 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.03 |